# Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer

> **NCT00421096** · PHASE2 · TERMINATED · sponsor: **Centre Oscar Lambret** · enrollment: 19 (actual)

## Conditions studied

- Uterine Cervical Cancer

## Interventions

- **DRUG:** Gemcitabine
- **PROCEDURE:** Radiotherapy
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00421096
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** 2008-04
- **Final completion:** 2011-12
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Problems of recruitment
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421096, "Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00421096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*